First Approval for Flozin/Metformin Combo (Xigduo) in EUFirst Approval for Flozin/Metformin Combo (Xigduo) in EU

The first-ever approval of a combination product containing an SGLT2 inhibitor (dapagliflozin) together with metformin for type 2 diabetes has been approved in the EU. International Approvals

Source: Medscape Diabetes Headlines - January 22, 2014 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news